Insider Transactions in Q1 2019 at Eli Lilly & CO (LLY)
Insider Transaction List (Q1 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.09%
|
$26,855,000
$131.71 P/Share
|
|
Mar 22
2019
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
1,000
-17.87%
|
$128,000
$128.5 P/Share
|
|
Mar 18
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
87
+0.2%
|
$10,875
$125.24 P/Share
|
|
Mar 18
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+1.0%
|
$10,625
$125.24 P/Share
|
|
Mar 18
2019
|
Ellen R Marram Director |
BUY
Grant, award, or other acquisition
|
Direct |
54
+0.1%
|
$6,750
$125.24 P/Share
|
|
Mar 18
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.03%
|
$2,000
$125.24 P/Share
|
|
Mar 18
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
79
+17.52%
|
$9,875
$125.24 P/Share
|
|
Mar 15
2019
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
SELL
Bona fide gift
|
Direct |
1,815
-8.22%
|
-
|
|
Mar 12
2019
|
Stephen F Fry SVP, HR & Diversity |
SELL
Open market or private sale
|
Direct |
14,847
-11.92%
|
$1,826,181
$123.16 P/Share
|
|
Mar 06
2019
|
Aarti S. Shah SVP & CIDO |
SELL
Bona fide gift
|
Direct |
1,105
-6.0%
|
-
|
|
Mar 01
2019
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
1,000
-15.16%
|
$127,000
$127.01 P/Share
|
|
Mar 01
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.06%
|
$26,880,000
$128.32 P/Share
|
|
Feb 28
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
200,000
-0.09%
|
$25,400,000
$127.01 P/Share
|
|
Feb 22
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
195,000
-0.17%
|
$24,180,000
$124.19 P/Share
|
|
Feb 19
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.09%
|
$25,010,000
$122.77 P/Share
|
|
Feb 19
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
81
+21.72%
|
$9,882
$122.13 P/Share
|
|
Feb 19
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.03%
|
$1,952
$122.13 P/Share
|
|
Feb 19
2019
|
Ellen R Marram Director |
BUY
Grant, award, or other acquisition
|
Direct |
55
+0.1%
|
$6,710
$122.13 P/Share
|
|
Feb 19
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
87
+1.04%
|
$10,614
$122.13 P/Share
|
|
Feb 19
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
89
+0.2%
|
$10,858
$122.13 P/Share
|
|
Feb 16
2019
|
Johna Norton EVP, Global Quality |
SELL
Payment of exercise price or tax liability
|
Indirect |
17
-20.73%
|
$2,074
$122.48 P/Share
|
|
Feb 16
2019
|
Johna Norton EVP, Global Quality |
BUY
Exercise of conversion of derivative security
|
Indirect |
48
+36.92%
|
-
|
|
Feb 15
2019
|
Enrique A Conterno SVP&Pres, LillyDiab & LillyUSA |
SELL
Open market or private sale
|
Direct |
25,000
-15.83%
|
$3,025,000
$121.0 P/Share
|
|
Feb 11
2019
|
Michael J Harrington Senior VP and General Counsel |
BUY
Bona fide gift
|
Indirect |
62,500
+50.0%
|
-
|
|
Feb 11
2019
|
Michael J Harrington Senior VP and General Counsel |
SELL
Bona fide gift
|
Direct |
62,500
-56.66%
|
-
|
|
Feb 04
2019
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
BUY
Grant, award, or other acquisition
|
Direct |
7,411
+21.65%
|
$889,320
$120.17 P/Share
|
|
Feb 04
2019
|
Enrique A Conterno SVP&Pres, LillyDiab & LillyUSA |
BUY
Grant, award, or other acquisition
|
Direct |
26,681
+14.45%
|
$3,201,720
$120.17 P/Share
|
|
Feb 04
2019
|
Stephen F Fry SVP, HR & Diversity |
BUY
Grant, award, or other acquisition
|
Direct |
19,404
+13.48%
|
$2,328,480
$120.17 P/Share
|
|
Feb 04
2019
|
Michael J Harrington Senior VP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
28,155
+18.23%
|
$3,378,600
$120.17 P/Share
|
|
Feb 04
2019
|
Johna Norton EVP, Global Quality |
BUY
Grant, award, or other acquisition
|
Direct |
2,958
+12.44%
|
$354,960
$120.17 P/Share
|
|
Feb 04
2019
|
David A Ricks President, Chair, and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
26,567
+14.81%
|
$3,188,040
$120.17 P/Share
|
|
Feb 04
2019
|
Aarti S. Shah SVP & CIDO |
BUY
Grant, award, or other acquisition
|
Direct |
5,939
+22.7%
|
$712,680
$120.17 P/Share
|
|
Feb 04
2019
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
BUY
Grant, award, or other acquisition
|
Direct |
15,619
+18.07%
|
$1,874,280
$120.17 P/Share
|
|
Feb 04
2019
|
Anne E. White EVP & Pres, Lilly Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
7,246
+25.61%
|
$869,520
$120.17 P/Share
|
|
Feb 04
2019
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
21,224
+23.84%
|
$2,546,880
$120.17 P/Share
|
|
Feb 04
2019
|
Joshua L Smiley |
BUY
Grant, award, or other acquisition
|
Direct |
9,954
+24.92%
|
$1,194,480
$120.17 P/Share
|
|
Feb 04
2019
|
Donald A Zakrowski SVP, Finance, & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
3,243
+32.97%
|
$389,160
$120.17 P/Share
|
|
Feb 04
2019
|
Myles O'Neill SVP & Pres., Mfg. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
8,592
+17.45%
|
$1,031,040
$120.17 P/Share
|
|
Feb 04
2019
|
Myles O'Neill SVP & Pres., Mfg. Operations |
BUY
Grant, award, or other acquisition
|
Indirect |
4,635
+7.48%
|
$556,200
$120.17 P/Share
|
|
Feb 01
2019
|
Myles O'Neill SVP & Pres., Mfg. Operations |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,491
-2.75%
|
$177,429
$119.86 P/Share
|
|
Feb 01
2019
|
Myles O'Neill SVP & Pres., Mfg. Operations |
BUY
Exercise of conversion of derivative security
|
Indirect |
3,221
+5.61%
|
-
|
|
Feb 01
2019
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
SELL
Payment of exercise price or tax liability
|
Direct |
1,492
-7.14%
|
$177,548
$119.86 P/Share
|
|
Feb 01
2019
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+13.75%
|
-
|
|
Feb 01
2019
|
Enrique A Conterno SVP&Pres, LillyDiab & LillyUSA |
SELL
Payment of exercise price or tax liability
|
Direct |
5,476
-4.0%
|
$651,644
$119.86 P/Share
|
|
Feb 01
2019
|
Enrique A Conterno SVP&Pres, LillyDiab & LillyUSA |
BUY
Exercise of conversion of derivative security
|
Direct |
12,222
+8.2%
|
-
|
|
Feb 01
2019
|
Stephen F Fry SVP, HR & Diversity |
SELL
Payment of exercise price or tax liability
|
Direct |
3,995
-3.66%
|
$475,405
$119.86 P/Share
|
|
Feb 01
2019
|
Stephen F Fry SVP, HR & Diversity |
BUY
Exercise of conversion of derivative security
|
Direct |
8,889
+7.53%
|
-
|
|
Feb 01
2019
|
Michael J Harrington Senior VP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,404
-4.29%
|
$524,076
$119.86 P/Share
|
|
Feb 01
2019
|
Michael J Harrington Senior VP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
12,778
+11.08%
|
-
|
|
Feb 01
2019
|
David A Ricks President, Chair, and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,485
-4.16%
|
$652,715
$119.86 P/Share
|